Detection of parvovirus B19 specific antibodies and DNa in sera of hemophiliacs
✍ Scribed by A. Große-Bley; A. M. Eis-Hübinger; R. Kaiser; J. Oldenburg; H. H. Brackmann; T. F. Schwarz; K. E. Schneweis
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 219 KB
- Volume
- 50
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human parvovirus B 19 commonly infects children, causing erythema infectiosum (fifth disease). However, there is a significant adult population which has not been exposed to the virus and, consequently, does not have protective antibody. Recent reports have associated B19 infection during pregnancy
## Abstract Human parvovirus B19 (B19) encodes a number of nonstructural proteins, including the major protein, NS1, and two structural proteins, VP1 and VP2. The use of denatured NS1 in enzyme‐linked immunosorbent assay (ELISA) and Western blot (WB) assay has provided an opportunity to study some
## Abstract To determine the diagnostic use of different markers of acute parvovirus 619 infection, serum specimens obtained from 128 persons with erythema infectiosum were tested for specific immunoglobulin G (IgG), IgA, and IgM antibodies by capture enzyme immunoassay (EIA) using Chinese hamster
## Abstract In the B19 VP2 molecule an immunodominant heptapeptide epitope has been detected, recently for which IgG antibodies are synthesized exclusively in the acute phase of B19 infection. Using this acute‐phase‐specific epitope (KYVTGIN) a 2^nd^‐generation epitope‐type EIA was developed, which
## Abstract Recent studies have suggested a pathogenic role of human parvovirus B19 (B19) in the development of acute fulminant liver failure in children. The hypothesis was based on the detection of B19 DNA in 8 of 10 explanted livers of children requiring liver transplantation. In the present stu